AI-generated summary
This study protocol describes a planned sham-controlled randomized trial in symptomatic soft contact lens wearers, combining 0.09% nanomicellar cyclosporine with intense pulsed light therapy. The authors plan to recruit 44 participants, using a symptom questionnaire as the primary outcome. No results are reported, as the paper describes the study design only.
- Participants
- 44
- Who or what was studied
- Symptomatic soft contact lens users recruited from a primary care optometry practice
- Limits stated in the abstract
- This is a study protocol only, so no efficacy or safety results are reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Sham, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.